Phathom Pharmaceuticals, Inc. (PHAT) Stock Total Returns
Growth of $10,000 chart
2021-04-14 to 2026-04-14 to
$
%
%
Loading chart…
Investment Performance
Final Value
$3,304
Total Return
-66.96%
CAGR
-19.87%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.54% |
| Median | -1.50% |
| Best | +285.59% |
| Worst | -53.73% |
| % of Windows Positive | 47.2% |
1-Year (252 Trading Days)
| Average | -4.81% |
| Median | -17.31% |
| Best | +208.27% |
| Worst | -82.25% |
| % of Windows Positive | 32.3% |
3-Year (756 Trading Days)
| Average | -20.29% |
| Median | -46.16% |
| Best | +102.72% |
| Worst | -83.60% |
| % of Windows Positive | 38.3% |
Risk Metrics
| Maximum Drawdown | -94.26% |
| Average Drawdown | -65.71% |
| Drawdown Duration | 1244 Trading Days (Unrecovered) |
| Sortino Ratio | 0.31 |
| Calmar Ratio | -0.21 |
| CVaR (5%) | -12.13% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -23.63% (-61.20% ann.) | $2362.86 | $0.00 | $0.00 | $0.00 |
| 2025 | +104.31% | +$10431.05 | $0.00 | $0.00 | $0.00 |
| 2024 | -11.06% | $1106.25 | $0.00 | $0.00 | $0.00 |
| 2023 | -18.63% | $1862.76 | $0.00 | $0.00 | $0.00 |
| 2022 | -42.96% | $4295.87 | $0.00 | $0.00 | $0.00 |
| 2021 | -40.79% | $4078.87 | $0.00 | $0.00 | $0.00 |
| 2020 | +6.68% | +$667.95 | $0.00 | $0.00 | $0.00 |
| 2019 partial | +26.59% (+261.53% ann.) | +$2658.54 | $0.00 | $0.00 | $0.00 |
Market Regimes
| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | October 25, 2019 – February 19, 2020 | +58.66% | +322.48% | +$5865.85 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -41.63% | -99.79% | $4162.97 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +60.50% | +114.10% | +$6049.99 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -55.16% | -53.27% | $5515.67 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -48.83% | -50.90% | $4882.94 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +79.69% | +37.19% | +$7968.89 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 14, 2026 | -34.11% | -23.35% | $3411.33 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.